HomeNECLIFE • NSE
add
Nectar Lifesciences Ltd
Nakaraang pagsara
₹38.22
Sakop ng araw
₹38.96 - ₹38.98
Sakop ng taon
₹26.15 - ₹56.50
Market cap
8.74B INR
Average na Volume
2.72M
P/E ratio
81.79
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.28B | 7.52% |
Gastos sa pagpapatakbo | 1.04B | 5.51% |
Net na kita | 55.99M | 451.45% |
Net profit margin | 1.31 | 403.85% |
Kita sa bawat share | — | — |
EBITDA | 432.89M | 61.08% |
Aktuwal na % ng binabayarang buwis | 35.39% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 187.35M | -7.94% |
Kabuuang asset | 21.83B | 1.89% |
Kabuuang sagutin | 11.05B | 2.80% |
Kabuuang equity | 10.78B | — |
Natitirang share | 223.96M | — |
Presyo para makapag-book | 0.79 | — |
Return on assets | — | — |
Return on capital | 4.07% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 55.99M | 451.45% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products. The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan. Wikipedia
Itinatag
1995
Headquarters
Website
Mga Empleyado
1,686
